✦ LIBER ✦
1319 SIMTUZUMAB, AN ANTIFIBROTIC MONOCLONAL ANTIBODY AGAINST LYSYL OXIDASE-LIKE 2 (LOXL2) ENZYME, APPEARS SAFE AND WELL TOLERATED IN PATIENTS WITH LIVER DISEASE OF DIVERSE ETIOLOGY
✍ Scribed by Talal, A.H.; Feron-Rigodon, M.; Madere, J.; Subramanian, G.M.; Bornstein, J.D.
- Book ID
- 122835541
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 57 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.